Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistance

Introduction: The most recent study to report Helicobacter pylori antibiotic resistance rates in Bangladesh was published 15 years ago and did not include levofloxacin. We therefore aimed to determine the current antibiotic susceptibility of H. pylori to amoxicillin, clarithromycin, metronidazole, t...

Full description

Saved in:
Bibliographic Details
Main Authors: Hafeza Aftab, Muhammad Miftahussurur, Phawinee Subsomwong, Faruque Ahmed, AK Azad Khan, Yoshio Yamaoka
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2016-03-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/7713
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850193122543271936
author Hafeza Aftab
Muhammad Miftahussurur
Phawinee Subsomwong
Faruque Ahmed
AK Azad Khan
Yoshio Yamaoka
author_facet Hafeza Aftab
Muhammad Miftahussurur
Phawinee Subsomwong
Faruque Ahmed
AK Azad Khan
Yoshio Yamaoka
author_sort Hafeza Aftab
collection DOAJ
description Introduction: The most recent study to report Helicobacter pylori antibiotic resistance rates in Bangladesh was published 15 years ago and did not include levofloxacin. We therefore aimed to determine the current antibiotic susceptibility of H. pylori to amoxicillin, clarithromycin, metronidazole, tetracycline and levofloxacin in Bangladesh. Methodology: This study included 133 consecutive patients who underwent endoscopy examination at Dhaka Medical College in November 2014. The serial two-fold agar dilution method was used to determine the minimum inhibitory concentrations of the five antibiotics. Results: Among 56 cultured strains, H. pylori showed high rates of resistance to clarithromycin and metronidazole (39.3% and 94.6%, respectively). Moreover, levofloxacin showed an emerging antimicrobial resistance pattern (66.1%), which was higher in patients with gastritis than that in those with peptic ulcers (p = 0.02). The resistance rate of levofloxacin was significantly higher in patients living in Dhaka city compared to those living in the village (p = 0.049). However, amoxicillin and tetracycline resistance rates were very low. Resistance to both metronidazole and levofloxacin was most commonly observed. Conclusions: The rates of resistance to clarithromycin, metronidazole, and levofloxacin were high in Bangladesh, which suggests that triple therapy based on these drugs may not be useful as first-line therapies in Bangladesh. Alternative strategies such as furazolidone-based triple therapy, bismuth-based quadruple therapies, or sequential therapy may be more effective for patients in in Bangladesh.
format Article
id doaj-art-92c4bbe3c9934ed499d67ea821e9c46e
institution OA Journals
issn 1972-2680
language English
publishDate 2016-03-01
publisher The Journal of Infection in Developing Countries
record_format Article
series Journal of Infection in Developing Countries
spelling doaj-art-92c4bbe3c9934ed499d67ea821e9c46e2025-08-20T02:14:20ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802016-03-01100310.3855/jidc.7713Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistanceHafeza Aftab0Muhammad Miftahussurur1Phawinee Subsomwong2Faruque Ahmed3AK Azad Khan4Yoshio Yamaoka5Oita University Faculty of Medicine, Yufu, JapanOita University Faculty of Medicine, Yufu, JapanOita University Faculty of Medicine, Yufu, JapanDhaka Medical College and Hospital, Dhaka, BangladeshBIRDEM, Dhaka, BangladeshOita University Faculty of Medicine, Yufu, JapanIntroduction: The most recent study to report Helicobacter pylori antibiotic resistance rates in Bangladesh was published 15 years ago and did not include levofloxacin. We therefore aimed to determine the current antibiotic susceptibility of H. pylori to amoxicillin, clarithromycin, metronidazole, tetracycline and levofloxacin in Bangladesh. Methodology: This study included 133 consecutive patients who underwent endoscopy examination at Dhaka Medical College in November 2014. The serial two-fold agar dilution method was used to determine the minimum inhibitory concentrations of the five antibiotics. Results: Among 56 cultured strains, H. pylori showed high rates of resistance to clarithromycin and metronidazole (39.3% and 94.6%, respectively). Moreover, levofloxacin showed an emerging antimicrobial resistance pattern (66.1%), which was higher in patients with gastritis than that in those with peptic ulcers (p = 0.02). The resistance rate of levofloxacin was significantly higher in patients living in Dhaka city compared to those living in the village (p = 0.049). However, amoxicillin and tetracycline resistance rates were very low. Resistance to both metronidazole and levofloxacin was most commonly observed. Conclusions: The rates of resistance to clarithromycin, metronidazole, and levofloxacin were high in Bangladesh, which suggests that triple therapy based on these drugs may not be useful as first-line therapies in Bangladesh. Alternative strategies such as furazolidone-based triple therapy, bismuth-based quadruple therapies, or sequential therapy may be more effective for patients in in Bangladesh. https://jidc.org/index.php/journal/article/view/7713Bangladeshdrug resistanceHelicobacter pylori
spellingShingle Hafeza Aftab
Muhammad Miftahussurur
Phawinee Subsomwong
Faruque Ahmed
AK Azad Khan
Yoshio Yamaoka
Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistance
Journal of Infection in Developing Countries
Bangladesh
drug resistance
Helicobacter pylori
title Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistance
title_full Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistance
title_fullStr Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistance
title_full_unstemmed Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistance
title_short Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistance
title_sort helicobacter pylori antibiotic susceptibility patterns in bangladesh emerging levofloxacin resistance
topic Bangladesh
drug resistance
Helicobacter pylori
url https://jidc.org/index.php/journal/article/view/7713
work_keys_str_mv AT hafezaaftab helicobacterpyloriantibioticsusceptibilitypatternsinbangladeshemerginglevofloxacinresistance
AT muhammadmiftahussurur helicobacterpyloriantibioticsusceptibilitypatternsinbangladeshemerginglevofloxacinresistance
AT phawineesubsomwong helicobacterpyloriantibioticsusceptibilitypatternsinbangladeshemerginglevofloxacinresistance
AT faruqueahmed helicobacterpyloriantibioticsusceptibilitypatternsinbangladeshemerginglevofloxacinresistance
AT akazadkhan helicobacterpyloriantibioticsusceptibilitypatternsinbangladeshemerginglevofloxacinresistance
AT yoshioyamaoka helicobacterpyloriantibioticsusceptibilitypatternsinbangladeshemerginglevofloxacinresistance